Insider Transactions in Q4 2023 at Cell Med X Corp. (CMXC)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2023
|
David Jeffs Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
15,000,000
+8.1%
|
$0
$0.01 P/Share
|
|
Dec 29
2023
|
David Jeffs Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,959,726
+50.0%
|
$0
$0.01 P/Share
|
|
Dec 29
2023
|
Richard Jeffs > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
14,372,285
+35.93%
|
$0
$0.01 P/Share
|
|
Dec 29
2023
|
Dwayne Yaretz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,214,285
+50.0%
|
$0
$0.01 P/Share
|
|
Dec 29
2023
|
Joao Da Costa Director |
BUY
Grant, award, or other acquisition
|
Indirect |
531,687
+20.5%
|
$0
$0.01 P/Share
|
|
Dec 29
2023
|
Amir Vahabzadeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
61,755,148
+48.73%
|
$0
$0.01 P/Share
|